Načítá se...
Medicare Coverage for Erythropoiesis-Stimulating Agents: The Perfect Storm
Medicare policy changes have an immediate impact on health plans with regard to setting payment policy for providers. So when Medicare tightened payment guidelines for a lucrative class of anemia drugs—erythropoiesis-stimulating agents—an ambitious set of rules was put into effect. Health plans ofte...
Uloženo v:
| Médium: | Artigo |
|---|---|
| Jazyk: | Inglês |
| Vydáno: |
Engage Healthcare Communications, LLC
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4106631/ https://ncbi.nlm.nih.gov/pubmed/25126232 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|